Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence With or Without Indocyanine Green for Parathyroid Identification
NCT06169735Phase 4Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in parathyroid anomaly and adenoma, sponsored by University of Alabama at Birmingham. Primary endpoint: Percentage of Parathyroid Glands identified by ICG at 20 minutes. Started Apr 2024; status: terminated.
02
Drugs
indocyanine green
03
Conditions
parathyroid anomalyadenoma
Beyond the preview
Go deeper on NCT06169735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06169735.